Montelukast Prescribing at RIVERSIDE SURGERY
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
905
Total Quantity
43.9K
NHS Cost
£2.0K
vs National Avg
+32.2%
RIVERSIDE SURGERY prescribed 905 items of Montelukast over the last 12 months at a cost of £1,964 to the NHS. This is 32.2% above the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
74
Jun 2026
71
Jun 2026
70
Jun 2026
71
Jun 2026
70
Jun 2026
76
Jun 2026
78
Jun 2026
74
Jun 2026
77
Jun 2026
73
Jun 2026
86
Jun 2026
85
Prescribing Details
| Total Items | 905 |
|---|---|
| Total Quantity | 43,896 |
| Total NHS Cost | £1,964 |
| Presentations | 4 different forms |
| vs National Average | +32.2% |
Montelukast Prescribing Comparison
| This practice | 905 items |
|---|---|
| National average per practice | 685 items |
| Difference | +32.2% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.